Key result
Severe ESUS (NIHSS ≥6) was associated with higher mortality compared to mild ESUS (adjusted HR 1.51; 95% CI 1.05-2.16), but had similar rates of stroke recurrence and new incident atrial fibrillation.
Why the study?
Patients with ESUS usually present with mild symptoms, leaving baseline characteristics, predictors, and clinical outcomes of severe ESUS compared to mild ESUS incompletely characterized.
Does severe ESUS compared to mild ESUS increase the risk of stroke recurrence, death, or incident AF in patients with embolic strokes of undetermined source?
Cohort (n=772)
Does severe ESUS compared to mild ESUS increase the risk of stroke recurrence, death, or incident AF in patients with embolic strokes of undetermined source?
Effect estimate: adjusted HR 1.51 (95% CI 1.05-2.16)
Absolute Event Rate: 5.4% vs 3.7%
In patients with ESUS, severe stroke at presentation is associated with higher long-term mortality but similar rates of stroke recurrence and incident AF compared to mild stroke.
Severe ESUS signals higher mortality without excess recurrence or AF; leaves open whether severity should guide monitoring or prevention intensity.
Background and aims Patients with embolic strokes of undetermined source (ESUS) usually present with mild symptoms. We aimed to compare the baseline characteristics between mild and severe ESUS, identify predictors for severe ESUS, and assess outcomes of patients with severe ESUS. Methods In the AF-ESUS (AF-ESUS) dataset, we stratified ESUS severity using the median National Institutes of Health Stroke Scale (NIHSS) score on admission as cut-off. We performed multivariable stepwise regression analyses to identify independent predictors of severe ESUS and to assess the association between ESUS severity and stroke recurrence, death, and new incident atrial fibrillation (AF) on follow-up. The 10-year cumulative probabilities of outcome incidence were estimated by the Kaplan–Meier product limit method. Results In 772 patients (median NIHSS: 6 (interquartile range: 3–12)), 414 (53.6%) patients had severe ESUS (i.e. NIHSS ≥6). Female sex was the only independent predictor for severe ESUS (odds ratio: 1.72 (1.27–2.33)). The rates of recurrence (3.3%/year vs. 3.4%/year, adjusted-hazard ratio: 1.09 (0.73–1.62)) and new incident AF (13.5% vs. 17.0%, adjusted odds ratio: 0.67 (0.44–1.03)) were similar between severe and mild ESUS, but mortality was higher (5.4%/year vs. 3.7%/year, adjusted-hazard ratio: 1.51 (1.05–2.16)) in severe ESUS. The 10-year cumulative probability for stroke recurrence was similar between severe and mild ESUS (38.1% (29.2–48.6) vs. 36.6% (27.8–47.0), log-rank test: 0.01, p = 0.920). The 10-year cumulative probability of death was higher in patients with severe ESUS compared with mild ESUS (40.5% (32.5–50.0) vs. 34.0% (26.0–43.6) respectively; log-rank test: 4.54, p = 0.033). Conclusions Women have more severe ESUS compared with men. Patients with severe ESUS have similar rates of stroke recurrence and new incident AF, but higher mortality compared with mild ESUS.
No takes yet. Share an insight, caveat, or question.
Leventis et al. (2020) conducted a cohort in Embolic strokes of undetermined source (ESUS) (n=772). Severe ESUS (NIHSS ≥6) vs. Mild ESUS (NIHSS <6) was evaluated on Mortality (adjusted HR 1.51, 95% CI 1.05-2.16). Severe ESUS (NIHSS ≥6) was associated with higher mortality compared to mild ESUS (adjusted HR 1.51; 95% CI 1.05-2.16), but had similar rates of stroke recurrence and new incident atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: